Stay updated on XMT-1660 in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1660 in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study title and drug name were updated from XMT-1660 to Emi-Le (Emiltatug Ledadotin), with new sponsor and contact details, expanded locations, and revised study dates and design (Phase 1/2 EMBLEM-1). The record now presents Emi-Le as the investigational drug and reflects the current recruitment status and endpoints.
    Difference
    2%
    Check dated 2026-06-30T00:37:26.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    New enrollment and help navigation items were added to the study details page, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. A formatting change in the Intervention/Treatment label replaces the previous Intervention / Treatment and the documentation revision note advanced from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T18:47:37.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov entry was published.
    Difference
    0.0%
    Check dated 2026-06-08T15:25:08.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 appears, replacing the previous Revision: v3.5.3. This indicates a minor metadata update to the page's release tag.
    Difference
    0.0%
    Check dated 2026-05-18T03:30:23.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from “v3.5.2” to “v3.5.3,” indicating a system/version update with no change to the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-26T08:22:48.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added UCLA David Geffen School of Medicine, Division of Hematology/Oncology and Sarah Cannon Research Institute (SCRI) with investigator Jennifer Specht, MD. Removed UCLA and Tennessee Oncology, PLLC and Natasha Hunter, MD.
    Difference
    0.3%
    Check dated 2026-04-19T01:26:36.000Z thumbnail image

Stay in the know with updates to XMT-1660 in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.